Sonendo has announced that management will participate in the upcoming LD Micro Main Event XVI Conference. The presentation is scheduled for Wednesday, October 4th at 2:30 PM Pacific Time/5:30 PM Eastern Time.
A webcast of the presentation will be accessible on the “Investors” section of the company’s website at: investor.sonendo.com.
About Sonendo
The company is focused on commercial-stage medical technology dedicated to combating tooth decay, the most prevalent chronic disease worldwide. Sonendo develops and manufactures the GentleWave System, an innovative technology platform designed to treat tooth decay by thoroughly cleaning and disinfecting the microscopic spaces within teeth, all without the need to remove tooth structure. The system employs a proprietary mechanism of action, combining procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.
The clinical benefits of the GentleWave System, when compared to conventional methods of root canal therapy, include improved clinical outcomes. This encompasses superior cleaning, which is independent of root canal complexity and tooth anatomy, high and rapid rates of healing, and minimal to no post-operative pain. Moreover, the GentleWave System can enhance the workflow and economics of dental practices. Sonendo is also the parent company of TDO Software, the developer of widely-used endodontic practice management software solutions designed to streamline practice workflow.
TDO Software integrates practice management, imaging, referral reporting, and CBCT imaging, and offers built-in communication with the GentleWave System.
For more information on Sonendo, visit www.sonendo.com. For more information on the GentleWave System, visit www.gentlewave.com/doctor.
